Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3855644)

Published in Ann Surg on April 01, 2014

Authors

Sayeda Nasrin Alam1, Halim Yammine, Omeed Moaven, Rizwan Ahmed, Angela K Moss, Brishti Biswas, Nur Muhammad, Rakesh Biswas, Atri Raychowdhury, Kanakaraju Kaliannan, Sathi Ghosh, Madhury Ray, Sulaiman R Hamarneh, Soumik Barua, Nondita S Malo, Atul K Bhan, Madhu S Malo, Richard A Hodin

Author Affiliations

1: *Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA †Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Articles cited by this

Host-bacterial mutualism in the human intestine. Science (2005) 26.39

Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol (2008) 12.16

Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) (1971) 7.03

Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology (1984) 6.17

Global trends in typhoid and paratyphoid Fever. Clin Infect Dis (2010) 5.25

HIV disease: fallout from a mucosal catastrophe? Nat Immunol (2006) 5.08

The core gut microbiome, energy balance and obesity. J Physiol (2009) 4.45

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol (2007) 4.09

Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe (2007) 3.88

CHANGES IN THE MOUSE'S ENTERIC MICROFLORA ASSOCIATED WITH ENHANCED SUSCEPTIBILITY TO SALMONELLA INFECTION FOLLOWING STREPTOMYCIN TREATMENT. J Infect Dis (1964) 3.75

Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun (2008) 3.68

A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65

IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci U S A (2001) 3.21

Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest (1994) 2.25

Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97

Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A (2008) 1.97

Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol (2003) 1.60

Clostridium difficile infection: a comprehensive review. Crit Rev Microbiol (2011) 1.48

Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J Pharmacol Exp Ther (2003) 1.45

Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol (2008) 1.40

Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut (2010) 1.31

Clostridium difficile--associated diarrhea. Am Fam Physician (2005) 1.28

Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm Bowel Dis (2011) 1.18

Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastrointest Liver Physiol (2010) 1.17

A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Dig Dis Sci (2010) 1.17

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis (2010) 1.11

The normal intestinal microbiota. Curr Opin Infect Dis (2007) 1.11

Clinical spectrum & pathogenesis of Clostridium difficile associated diseases. Indian J Med Res (2010) 1.05

Salmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the Organism. Front Microbiol (2011) 1.04

Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996-1997. Clin Infect Dis (2004) 1.03

A study of invasiveness of different Salmonella serovars based on analysis of the Enter-net database. Euro Surveill (2007) 0.94

Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. Clin Chem (2010) 0.92

Killed but metabolically active Salmonella typhimurium: application of a new technology to an old vector. J Infect Dis (2007) 0.88

Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes. Am J Physiol (1989) 0.87

Clostridium difficile-associated Enteric Disease. Curr Infect Dis Rep (2002) 0.86

Small intestine and microbiota. Curr Opin Gastroenterol (2011) 0.84

Local peritoneal irrigation with intestinal alkaline phosphatase is protective against peritonitis in mice. J Gastrointest Surg (2011) 0.83

Inorganic pyrophosphatase as a label in heterogeneous enzyme immunoassay. Anal Biochem (1988) 0.82

[Risk factor for antibiotic-associated diarrhea. A review of the literature]. Ann Med Interne (Paris) (1998) 0.79

[Clostridum difficile associated disease in Latin America]. Gac Med Mex (2009) 0.79

A numerical taxonomic study of a group of selected strongylates (Nematoda). Syst Zool (1969) 0.78

Articles by these authors

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med (2004) 7.67

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17

Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity (2002) 4.60

mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature (2012) 3.51

Sigmoidectomy syndrome? Patients' perspectives on the functional outcomes following surgery for diverticulitis. Dis Colon Rectum (2012) 3.28

A case for regulatory B cells. J Immunol (2006) 3.20

Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A (2004) 2.57

The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int (2009) 2.33

Chilaiditi syndrome: a rare entity with important differential diagnoses. Gastroenterol Hepatol (N Y) (2012) 2.27

Identification of surgical complications and deaths: an assessment of the traditional surgical morbidity and mortality conference compared with the American College of Surgeons-National Surgical Quality Improvement Program. J Am Coll Surg (2006) 2.07

B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A (2010) 2.03

Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature (2011) 1.98

Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A (2008) 1.97

Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A (2013) 1.89

The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med (2007) 1.81

Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery. Gastroenterology (2004) 1.78

The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr (2002) 1.68

Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg (2004) 1.64

Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med (2004) 1.48

Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology (2002) 1.45

Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res (2012) 1.45

CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med (2007) 1.41

Primary hyperparathyroidism after Roux-en-Y gastric bypass. Obes Surg (2015) 1.39

Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology (2013) 1.38

Survival after brain metastases from breast cancer in the trastuzumab era. J Clin Oncol (2005) 1.36

Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood (2002) 1.35

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer (2007) 1.30

Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppel-like factor. Am J Physiol Gastrointest Liver Physiol (2003) 1.29

Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist (2011) 1.27

Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology (2003) 1.25

Regulatory role of B-1 B cells in chronic colitis. Int Immunol (2008) 1.25

Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Gastroenterology (2007) 1.21

Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. J Natl Cancer Inst (2013) 1.19

Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis. Inflamm Bowel Dis (2011) 1.18

Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice. Gastroenterology (2009) 1.18

Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. Radiology (2009) 1.17

Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase. Am J Physiol Gastrointest Liver Physiol (2010) 1.17

A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Dig Dis Sci (2010) 1.17

Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol (2002) 1.15

Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer. Endocrinology (2011) 1.13

Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J Clin Invest (2007) 1.12

Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol (2008) 1.08

Control freaks: immune regulatory cells. Nat Immunol (2004) 1.08

p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol (2008) 1.07

Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention. Am J Physiol Heart Circ Physiol (2009) 1.06

Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis (2003) 1.06

p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer (2010) 1.06

Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology (2005) 1.05

Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology (2007) 1.03

Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J Allergy Clin Immunol (2002) 1.02

Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer. Surgery (2010) 1.00

A unique B2 B cell subset in the intestine. J Exp Med (2008) 1.00

The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol (2005) 1.00

BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery (2012) 0.99

Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg (2009) 0.99

Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection. J Hepatol (2009) 0.98

Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate. Am J Physiol Gastrointest Liver Physiol (2013) 0.98

Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid (2010) 0.96

Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol (2010) 0.95

Role of the CD5 molecule on TCR gammadelta T cell-mediated immune functions: development of germinal centers and chronic intestinal inflammation. Int Immunol (2003) 0.94

Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice. Gastroenterology (2007) 0.93

The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression. DNA Cell Biol (2006) 0.93

Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology (2014) 0.93

Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma. BMC Cancer (2010) 0.93

CD48 controls T-cell and antigen-presenting cell functions in experimental colitis. Gastroenterology (2006) 0.93

Thyroid surgery in octogenarians is associated with higher complication rates. Surgery (2009) 0.92

Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy. Ann Surg Oncol (2012) 0.91

Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy. Cancer Biol Ther (2011) 0.91

p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation. J Immunol (2012) 0.91

Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant (2004) 0.91

A diabetic with recent blindness and paralysis of one eye. BMJ Case Rep (2010) 0.90

Factors associated with conversion to laparotomy in patients undergoing laparoscopic appendectomy. J Am Coll Surg (2002) 0.90

Essential role for Vav1 in activation, but not development, of gammadelta T cells. Int Immunol (2003) 0.90